ALGAE Fermentalg SA
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.…
Industry Peers
BiotechnologyKey Statistics
About Fermentalg (EPA: ALGAE)
›
Fermentalg (EPA: ALGAE) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 62 employees.
The shares were at 0.3960 EUR on 19 November 2026, down 6.8% over 52 weeks. Its 52-week range is 0.3505 EUR to 0.6400 EUR: the price is 38.1% below the high and 13.0% above the low.
Its market capitalisation is 47.33M EUR.
Fermentalg reports return on equity of -37.5%, an operating margin of -82.5% and revenue down 2.5% year over year.
It holds more cash than debt, a net cash position of 6.85M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 2 analysts cover the stock; their mean price target of 0.4950 EUR is 25.0% above the current price.